Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
2000 1
2001 1
2002 1
2003 1
2004 1
2005 3
2006 1
2007 5
2008 5
2009 1
2010 3
2011 4
2012 4
2013 9
2014 9
2015 5
2016 4
2017 5
2018 8
2019 7
2020 12
2021 6
2022 10
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T. Luna G, et al. Among authors: fogdell hahn a. JAMA Neurol. 2020 Feb 1;77(2):184-191. doi: 10.1001/jamaneurol.2019.3365. JAMA Neurol. 2020. PMID: 31589278 Free PMC article.
Prediction of natalizumab anti-drug antibodies persistency.
Deisenhammer F, Jank M, Lauren A, Sjödin A, Ryner M, Fogdell-Hahn A, Sievers C, Lindberg R, Jensen PE, Sellebjerg F, Christodoulou L, Birchler M, Pallardy M, Auer M, Liblau R; ABIRISK consortium. Deisenhammer F, et al. Among authors: fogdell hahn a. Mult Scler. 2019 Mar;25(3):392-398. doi: 10.1177/1352458517753721. Epub 2018 Jan 16. Mult Scler. 2019. PMID: 29336205
Modulatory effects on dendritic cells by human herpesvirus 6.
Gustafsson R, Svensson M, Fogdell-Hahn A. Gustafsson R, et al. Among authors: fogdell hahn a. Front Microbiol. 2015 Apr 30;6:388. doi: 10.3389/fmicb.2015.00388. eCollection 2015. Front Microbiol. 2015. PMID: 25983728 Free PMC article. Review.
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier.
Kharlamova N, Hermanrud C, Dunn N, Ryner M, Hambardzumyan K, Vivar Pomiano N, Marits P, Gjertsson I, Saevarsdottir S, Pullerits R, Fogdell-Hahn A. Kharlamova N, et al. Among authors: fogdell hahn a. Front Immunol. 2020 Jul 21;11:1365. doi: 10.3389/fimmu.2020.01365. eCollection 2020. Front Immunol. 2020. PMID: 32793189 Free PMC article.
10th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.
Tourdot S, Abdolzade-Bavil A, Bessa J, Broët P, Fogdell-Hahn A, Giorgi M, Jawa V, Kuranda K, Legrand N, Pattijn S, Pedras-Vasconcelos JA, Rudy A, Salmikangas P, Scott DW, Snoeck V, Smith N, Spindeldreher S, Kramer D. Tourdot S, et al. Among authors: fogdell hahn a. MAbs. 2020 Jan-Dec;12(1):1725369. doi: 10.1080/19420862.2020.1725369. MAbs. 2020. PMID: 32063088 Free PMC article.
94 results